Genprex, Inc. (GNPX)
2.83
+0.01
(+0.35%)
USD |
NASDAQ |
Jan 21, 10:02
Genprex Free Cash Flow: -15.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arvinas, Inc. | -- |
| Olema Pharmaceuticals, Inc. | -134.67M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.187M |
| Cash from Financing (Quarterly) | 2.944M |
| Free Cash Flow Per Share (Quarterly) | -4.191 |
| Free Cash Flow to Equity (Quarterly) | -3.187M |
| Free Cash Flow to Firm (Quarterly) | -3.187M |
| Free Cash Flow Yield | -126.9% |